rdf:type |
|
lifeskim:mentions |
umls-concept:C0000768,
umls-concept:C0011860,
umls-concept:C0012155,
umls-concept:C0017628,
umls-concept:C0030705,
umls-concept:C0087111,
umls-concept:C0311400,
umls-concept:C0532578,
umls-concept:C1280500,
umls-concept:C1518321,
umls-concept:C1563742
|
pubmed:issue |
4
|
pubmed:dateCreated |
2002-3-28
|
pubmed:abstractText |
OBJECTIVE; To examine the effects of diet and diet with voglibose or glyburide on abdominal adiposity and metabolic abnormalities in patients with type 2 diabetes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Inositol,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/voglibose
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0149-5992
|
pubmed:author |
pubmed-author:HayashiMakotoM,
pubmed-author:KawachiShin-ichiS,
pubmed-author:KokuboYoshiakiY,
pubmed-author:NakashimaKazuyaK,
pubmed-author:OzekiShigehikoS,
pubmed-author:SasakiAkihikoA,
pubmed-author:SatoMayumiM,
pubmed-author:TakamiKazuhisaK,
pubmed-author:TakamiRiekoR,
pubmed-author:TakedaNoriyukiN,
pubmed-author:YamadaAkikoA,
pubmed-author:YasudaKeigoK
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
658-62
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11919121-Abdomen,
pubmed-meshheading:11919121-Adipose Tissue,
pubmed-meshheading:11919121-Adult,
pubmed-meshheading:11919121-Blood Glucose,
pubmed-meshheading:11919121-Body Mass Index,
pubmed-meshheading:11919121-Body Weight,
pubmed-meshheading:11919121-Cholesterol,
pubmed-meshheading:11919121-Cholesterol, HDL,
pubmed-meshheading:11919121-Diabetes Mellitus, Type 2,
pubmed-meshheading:11919121-Diabetic Diet,
pubmed-meshheading:11919121-Energy Intake,
pubmed-meshheading:11919121-Fasting,
pubmed-meshheading:11919121-Fatty Acids, Nonesterified,
pubmed-meshheading:11919121-Female,
pubmed-meshheading:11919121-Glucose Tolerance Test,
pubmed-meshheading:11919121-Glyburide,
pubmed-meshheading:11919121-Hemoglobin A, Glycosylated,
pubmed-meshheading:11919121-Humans,
pubmed-meshheading:11919121-Hypoglycemic Agents,
pubmed-meshheading:11919121-Inositol,
pubmed-meshheading:11919121-Insulin,
pubmed-meshheading:11919121-Male,
pubmed-meshheading:11919121-Triglycerides
|
pubmed:year |
2002
|
pubmed:articleTitle |
Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes.
|
pubmed:affiliation |
Department of Internal Medicine, Kizawa Memorial Hospital, Gifu, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|